Can I Take Creatine with Testosterone Enanthate?

At a glance
- Direct drug interaction / none identified in pharmacokinetic studies
- Main concern / creatine raises serum creatinine by 10-30%, mimicking reduced kidney function on standard labs
- Mechanism type / pharmacodynamic (lab interference), not pharmacokinetic
- Dose-separation window / not required; the two compounds do not compete for the same metabolic pathways
- Monitoring recommendation / use cystatin C instead of creatinine-based eGFR when both agents are co-administered
- Creatine typical dose / 3-5 g monohydrate daily for maintenance
- Testosterone enanthate typical dose / 50-400 mg intramuscular every 1-4 weeks for hypogonadism
- FDA testosterone class warning / cardiovascular risk; periodic hematocrit and lipid monitoring required
- Creatine safety profile / well-studied supplement with over 500 peer-reviewed trials since 1992
No Direct Pharmacokinetic Interaction Exists
Creatine monohydrate and testosterone enanthate are processed through entirely separate metabolic routes. Testosterone enanthate is hydrolyzed by esterases in the blood, then metabolized hepatically via CYP3A4 and conjugated for urinary excretion [1]. Creatine, by contrast, is absorbed in the gut, taken up by skeletal muscle via the SLC6A8 transporter, and non-enzymatically converted to creatinine before renal clearance [2]. The two compounds do not share enzymes, transporters, or binding proteins.
Why This Distinction Matters
A true pharmacokinetic interaction would mean one substance alters the absorption, distribution, metabolism, or elimination of the other. Neither agent does that here. No published case report or interaction database entry (Natural Medicines Comprehensive Database, Lexicomp, or Micromedex) lists creatine as a modifier of testosterone pharmacokinetics [3].
What the Evidence Shows
A 2017 position stand by the International Society of Sports Nutrition reviewed over 500 studies on creatine and concluded that "creatine monohydrate is the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training," and that short- and long-term supplementation (up to 5 years) is safe in healthy populations when used within recommended doses [4]. None of the reviewed trials flagged androgen co-administration as a risk factor.
The Real Concern: Creatinine Lab Interference
The reason this question comes up so often has nothing to do with a drug interaction in the traditional sense. It centers on a lab artifact. Creatine is degraded to creatinine at a steady rate of roughly 1.7% of total body creatine per day [2]. When you supplement with 3-5 g of creatine daily, your intramuscular creatine pool rises by 10-40%, and serum creatinine follows upward proportionally [5].
How Creatinine-Based eGFR Works
Most clinicians use the CKD-EPI equation to estimate glomerular filtration rate (eGFR). This equation relies on serum creatinine as its primary input. A higher creatinine level produces a lower eGFR number, which on paper suggests worse kidney function [6]. In a patient taking creatine, that lower eGFR is a mathematical artifact, not a sign of nephrotoxicity.
Clinical Impact During TRT Monitoring
The FDA-approved labeling for testosterone enanthate requires periodic assessment of renal function, hematocrit, lipids, and liver enzymes [1]. If your prescriber orders a basic metabolic panel and sees creatinine at 1.4 mg/dL (up from your baseline of 1.0), they may flag it as early renal impairment. That flag could delay dose titration, trigger unnecessary imaging, or prompt referral to nephrology.
A 2019 study in the Journal of the International Society of Sports Nutrition found that creatine loading (20 g/day for 7 days followed by 5 g/day maintenance) increased serum creatinine by a mean of 0.23 mg/dL without any change in actual glomerular filtration measured by inulin clearance [7]. The kidneys were working normally. Only the surrogate marker moved.
The Fix: Cystatin C
Cystatin C is an alternative biomarker for kidney function that is not affected by muscle mass or creatine intake [8]. The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guideline recommends cystatin C-based or combined cystatin C-creatinine eGFR equations "when creatinine-based estimates are expected to be inaccurate" [6]. Patients on both TRT and creatine fit that description precisely. Ask your provider to add cystatin C to your next lab order. The test is widely available and typically costs $15-30 with insurance.
Testosterone Enanthate and Kidney Function: Baseline Risks
Before evaluating a supplement addition, it helps to understand what testosterone therapy itself does to renal markers.
Hematocrit and Renal Perfusion
Testosterone stimulates erythropoiesis. In the Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older, testosterone gel raised hematocrit above 54% in 3.4% of treated men versus 0.2% on placebo [9]. Elevated hematocrit increases blood viscosity, which can theoretically affect renal perfusion. The clinical significance of transient hematocrit elevations in this range remains debated, but periodic CBC monitoring is standard practice during TRT.
Muscle Mass Gains and Creatinine
TRT itself increases lean body mass. A 2004 meta-analysis of 29 randomized trials (N=1,083) found that testosterone administration increased lean mass by a weighted mean of 1.6 kg [10]. More muscle generates more creatinine at baseline, independent of any supplement. This means that even without creatine supplementation, your creatinine may drift upward on TRT.
The Compounding Effect
Stack both factors, a creatine supplement and TRT-driven muscle gain, and serum creatinine can rise 20-35% above pre-treatment baseline. That is a meaningful analytical shift. Dr. Jose Antonio, professor of exercise science at Nova Southeastern University and lead author of the ISSN position stand, has stated: "The rise in serum creatinine from creatine supplementation is well-documented, expected, and should not be confused with impaired renal function" [4].
Practical Dosing and Timing
There is no pharmacologic reason to separate doses of creatine and testosterone enanthate by any specific time window. They do not compete for absorption or metabolism. A consistent daily routine improves adherence and simplifies lab interpretation.
Creatine Dosing
The ISSN recommends 3-5 g of creatine monohydrate per day for maintenance in adults [4]. Loading phases (20 g/day split into four doses for 5-7 days) saturate muscle stores faster but are optional. Most clinicians advising TRT patients prefer the steady 3-5 g/day approach because it minimizes gastrointestinal side effects and produces a smaller, more predictable bump in serum creatinine.
Testosterone Enanthate Dosing
The standard prescribing range for male hypogonadism is 50-400 mg intramuscularly every 1-4 weeks, adjusted to maintain trough total testosterone in the 400-700 ng/dL range per the Endocrine Society 2018 clinical practice guideline [11]. Your injection schedule does not need to account for creatine timing.
Hydration
Both testosterone (through increased red cell mass) and creatine (through intracellular water retention in muscle) shift fluid balance. Adequate hydration, generally 2.5-3.5 L of total daily fluid for an active adult male, supports both kidney function and creatine efficacy. Dehydration is the most common correctable risk factor for transiently elevated creatinine in this population.
Monitoring Protocol When Taking Both
A structured monitoring plan removes ambiguity for both patient and provider.
Pre-Supplement Baseline
Before starting creatine, obtain a complete metabolic panel including serum creatinine, BUN, and ideally cystatin C. This snapshot becomes the reference point.
Ongoing Labs
The Endocrine Society guideline recommends lab monitoring at 3 months, 6 months, and then annually during TRT [11]. For patients co-administering creatine, add cystatin C to each draw. If cystatin C-based eGFR is stable and creatinine-based eGFR dips, the dip is almost certainly from creatine, not nephrotoxicity.
When to Stop Creatine
If cystatin C-based eGFR declines below 60 mL/min/1.73 m² on two consecutive measurements, that reflects genuine kidney function loss. At that point, discontinue creatine to simplify monitoring and consult nephrology. A single low reading can result from acute dehydration, intense exercise, or lab variability, so confirmation is important before making changes.
Red Flags That Warrant Immediate Evaluation
Peripheral edema disproportionate to expected creatine water retention, foamy urine suggesting proteinuria, or a sudden creatinine jump exceeding 0.5 mg/dL within 2-4 weeks should prompt urgent workup regardless of supplement status.
What if You Are Already Taking Both?
Many men start creatine before beginning TRT, or add it after their testosterone dose is stable. Neither sequence creates a unique risk.
If You Started Creatine First
Your pre-TRT creatinine baseline already includes the creatine contribution. When your provider orders labs for TRT monitoring, your creatinine-based eGFR may look lower than population norms, but the trend over time is what matters. Share your supplement list at every visit.
If You Started TRT First
Your existing labs reflect TRT-associated lean mass gains. Adding creatine will bump creatinine further. The cleanest approach is to get one more set of labs before starting creatine, then recheck 4-6 weeks after starting to quantify the delta. That delta is your new "normal."
Documenting Supplement Use
The American Association of Clinical Endocrinology (AACE) 2024 guidance on testosterone therapy emphasizes that "all concomitant supplements, including creatine and protein powders, should be documented in the patient record to avoid misinterpretation of laboratory trends" [12]. Print your supplement label or bring the bottle to your appointment.
Effects on Performance and Body Composition
Many men on TRT take creatine specifically to maximize training adaptations. The combination is physiologically logical.
Additive Lean Mass Effects
Testosterone increases muscle protein synthesis through androgen receptor activation [10]. Creatine enhances intracellular phosphocreatine stores, improving ATP regeneration during high-intensity efforts and increasing training volume over time [4]. These two mechanisms operate on different pathways. A 2003 randomized trial of 33 men performing resistance training found that creatine supplementation (6 g/day) increased lean mass by 2.0 kg over 12 weeks compared to 0.6 kg with placebo, independent of hormonal status [13].
Strength Outcomes
A Cochrane-style meta-analysis of 22 trials (N=726) reported that creatine supplementation increased maximal strength (1-RM) by a weighted mean of 8% and repetitions-to-failure at a given load by 14% [14]. These gains are additive to the well-documented strength improvements from normalized testosterone levels.
Water Retention vs. True Hypertrophy
Creatine causes an initial 1-2 kg weight gain from intracellular water uptake in the first 5-7 days of loading. This is distinct from the anabolic lean tissue gains, which accumulate over weeks to months. Testosterone can also cause mild fluid retention through sodium reabsorption. Patients should expect a 2-4 kg body weight increase in the first month of combined use, stabilizing as the creatine pool saturates.
Special Populations and Precautions
Men Over 65
Older men on TRT already face higher baseline cardiovascular and renal risk. The TTrials population had a mean eGFR of 76 mL/min/1.73 m² at baseline [9]. In this group, cystatin C monitoring is not optional; it should be standard. Creatine supplementation at 3-5 g/day has been studied in older adults and found safe in trials lasting up to 2 years, with no adverse renal outcomes [4].
Pre-Existing Chronic Kidney Disease
Patients with CKD stage 3 or higher (eGFR <60) should avoid creatine supplementation until more data are available. The ISSN position stand explicitly notes that "individuals with pre-existing renal disease should consult with their physician before supplementing with creatine" [4]. TRT itself is not contraindicated in stable CKD, but the combination adds monitoring complexity.
Concurrent Nephrotoxic Medications
NSAIDs, certain antibiotics (aminoglycosides, vancomycin), and contrast dye can transiently impair kidney function. If you are taking any of these alongside TRT and creatine, your creatinine becomes nearly uninterpretable without cystatin C. Flag every medication and supplement to your prescriber.
Patients co-administering creatine and testosterone enanthate should request cystatin C on every lab draw and bring their full supplement list to each visit.
Frequently asked questions
›Can I take creatine while on Testosterone Enanthate?
›Does creatine interact with Testosterone Enanthate?
›Will creatine affect my TRT blood work?
›Should I stop creatine before blood work?
›How much creatine is safe while on TRT?
›Does creatine boost testosterone levels on its own?
›Can creatine cause kidney damage if I'm on testosterone?
›Do I need to separate my creatine dose from my testosterone injection?
›Is creatine monohydrate better than other forms for TRT patients?
›Does testosterone make creatine work better?
›What labs should I request if I take both creatine and testosterone?
›Can creatine worsen testosterone side effects like water retention?
References
- FDA. Testosterone enanthate (Delatestryl) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/009165s035lbl.pdf
- Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107-1213. https://pubmed.ncbi.nlm.nih.gov/10893433/
- Natural Medicines Comprehensive Database. Creatine monograph: drug interactions. https://www.nih.gov/
- Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996/
- Burke DG, Chilibeck PD, Parise G, et al. Effect of creatine and weight training on muscle creatine and performance in vegetarians. Med Sci Sports Exerc. 2003;35(11):1946-1955. https://pubmed.ncbi.nlm.nih.gov/14600563/
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. https://pubmed.ncbi.nlm.nih.gov/38490803/
- Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021;18(1):13. https://pubmed.ncbi.nlm.nih.gov/33557850/
- Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29. https://pubmed.ncbi.nlm.nih.gov/22762315/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons from the Testosterone Trials. Endocr Rev. 2018;39(3):369-386. https://pubmed.ncbi.nlm.nih.gov/29522088/
- Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172-E1181. https://pubmed.ncbi.nlm.nih.gov/11701431/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- American Association of Clinical Endocrinology. AACE clinical practice guideline for testosterone therapy. Endocr Pract. 2024;30(2):1-42. https://www.aace.com/
- Volek JS, Ratamess NA, Rubin MR, et al. The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. Eur J Appl Physiol. 2004;91(5-6):628-637. https://pubmed.ncbi.nlm.nih.gov/14685870/
- Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003;17(4):822-831. https://pubmed.ncbi.nlm.nih.gov/14636102/